Nostrum Biodiscovery

Nostrum Biodiscovery S.L. is a Spain‑based biotech company specialized in developing AI-based molecular modeling tools for drug discovery in the areas of small molecules, targeted protein degradation, oligonucleotides design, or antibodies de novo design. The company merges cutting‑edge in silico modeling tools & artificial intelligence algorithms with deep scientific expertise to accelerate drug discovery, biomolecular engineering, and molecular optimization.

Key features:

• Algorithm-driven molecular design: From ligand screening to lead optimization using advanced computational pipelines

• Drug discovery support: Target identification, virtual screening, ADMET prediction, and synthetic accessibility assessment

• Bioinformatics and structural biology: RNA/DNA modeling, protein structure prediction, and molecular dynamics simulations

• Client-focused service: Agile project delivery, customized workflows, and close collaboration with pharmaceutical and biotech partners

Nostrum Biodiscovery’s mission is to reduce R&D costs and timelines by integrating high-performance computation, AI‑based modeling, and expert validation—bridging computational innovation with real-world experimental impact.